Current management of glioblastoma multiforme

Seminars in Oncology

Volumn 31, Issue 5, 2004, Pages 635-644

  Grossman, Stuart A ^a   Batara, Julette F ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; 9 AMINOCAMPTOTHECIN; ANTICONVULSIVE AGENT; BORTEZOMIB; CARBOPLATIN; CARMUSTINE; CELECOXIB; CILENGITIDE; CISPLATIN; DIAZIQUONE; EFAPROXIRAL; ERLOTINIB; EVEROLIMUS; FLUOROURACIL; GADOLINIUM; GLUCOCORTICOID; HYDROXYUREA; IRINOTECAN; LOMUSTINE; LONAFARNIB; MARIMASTAT; METHYLPREDNISOLONE; MITOLACTOL; PACLITAXEL; PRINOMASTAT; PROCARBAZINE; PYRIMIDINE DERIVATIVE; SEMAXANIB; TEMOZOLOMIDE; TEMSIROLIMUS; TENIPOSIDE; THALIDOMIDE; TIPIFARNIB; UNINDEXED DRUG; VATALANIB; VINCRISTINE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG RESISTANCE; DRUG TOLERANCE; GLIOBLASTOMA; HUMAN; NEUROTOXICITY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECTUM CANCER; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; TUMOR CELL;

ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; GLIOBLASTOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 6344228279     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.07.005     Document Type: Article

References (100)

1. A. Jemal, A. Thomas, T. Murray Cancer statistics, 2002 CA Cancer J Clin 52 2002 23 47
2. T.S. Surawicz, B.J. McCarthy, V. Kupelian Descriptive epidemiology of primary brain and CNS tumors Results from the Central Brain Tumor Registry of the United States, 1990-1994 Neurooncology 1 1999 14 25
3. J.S. Barnholtz-Sloan, A.E. Sloan, A.G. Schwartz Racial differences in survival after diagnosis with primary malignant brain tumor Cancer 98 2003 603 609
4. M. Wrensch, Y. Minn, T. Chew Epidemiology of primary brain tumors Current concepts and review of the literature Neurooncology 4 2002 278 299
5. M. Salvati, M. Artico, R. Caruso A report on radiation-induced gliomas Cancer 67 1991 392 397
6. S.A. Grossman, M. Osman, R. Hruban Central nervous system cancers in first-degree relatives and spouses Cancer Invest 17 1999 299 308
7. B. Malmer, R. Henriksson, H. Gronberg Familial brain tumors--Genetics or environment? A nationwide ohort study of cancer risk in spouses and first-degree relatives of brain tumour patients Int J Cancer 106 2003 260 263
8. G.J. Kitange, K.L. Templeton, R.B. Jenkins Recent advances in the molecular genetics of primary gliomas Curr Opin Oncol 15 2003 197 203
9. P. Kleihues, P.C. Burger, B.W. Scheithauer Histological typing of tumors of the central nervous system 1993 World Health Organization Geneva, Switzerland
10. M.D. Walker, S.B. Green, D.P. Byar Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 1980 1323 1329
11. P.C. Burger The anatomy of astrocytomas Mayo Clin Proc 65 1987 527 529
12. E.C. Halperin, P.C. Burger, D.E. Bullard The fallacy of the localized supratentorial malignant glioma Int J Radiat Oncol Biol Phys 15 1988 505 509
13. M.R. Fetell, S.A. Grossman, J. Fisher Pre-irradiation paclitaxel in glioblastoma multiforme Efficacy, pharmacology, and drug interactions J Clin Oncol 15 1997 3121 3128
14. M.R. Gilbert, J. Supko, T. Batchelor Phase I study of CPT-11 in patients with recurrent malignant glioma A study of the NABTT CNS Consortium Clin Cancer Res 9 2003 2940 2949
15. S.A. Grossman, F. Hochberg, J.D. Fisher Increased 9-aminocamptothecin requirements in patients on anticonvulsants Cancer Chemother Pharmacol 42 1998 118 126
16. C.J. Vecht, G.L. Wagner, E.B. Wilms Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 2003 404 409
17. S.A. Grossman, J. Supko, S. Phupanich Phase I/II study of oral procarbazine in the treatment of recurrent high grade astrocytomas Neurooncology 3 2001 358 359 abstr
18. J.M. Nazzarro, E.A. Neuwelt The role of surgery in the management of supratentorial intermediate and high grade astrocytomas in adults J Neurosurg 73 1990 331 334
19. F.W. Kreth, A. Berlis, V. Spiropoulou The role of tumor resection in the treatment of glioblastoma multiforme in adults Cancer 86 1999 2117 2123
20. S.A. Grossman, V. Levin, R. Sawaya National Comprehensive Cancer Network adult brain tumor practice guidelines Oncology 11 1997 237 277
21. M.D. Walker, E. Alexander, W.E. Hunt Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas A cooperative clinical trial J Neurosurg 49 1978 333 343
22. A.P. Anderson Postoperative irradiation of GBM. Results in a randomized series Acta Radiol Oncol 17 1978 475 484
23. K. Kristiansen, S. Hagen, T. Kollevold A prospective multicenter trial of the Scandinavian Glioblastoma Study Group Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time Cancer 47 1981 649 652
24. M. Sandberg-Wohlheim, P. Malmstrom, L.G. Stromblad A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4 Cancer 68 1991 22 29
25. W.R. Shapiro, F. Dean, D.F. Young Treatment of malignant glioma. A controlled study of chemotherapy and irradiation Arch Neurol 33 1976 494 500
26. W.R. Shapiro, S.B. Green, P.C. Burger Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma Brain Tumor Cooperative Group Trial 8001 J Neurosurg 71 1989 1 9
27. M.D. Walker, T.A. Strike, G.E. Sheline An analysis of dose-effect relationship in the radiotherapy of malignant gliomas Int J Radiat Oncol Biol Phys 5 1979 1725 1731
28. C.H. Chang, J. Orton, D. Schoenfeld Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of gliomas Cancer 52 1983 997 1007
29. N.M. Bleehan, S.P. Stenning A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma Br J Cancer 43 1981 436 442
30. C. Phillipps, M. Guiney, J. Smith A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme in older patients with anaplastic astrocytoma Radiother Oncol 68 2003 23 26
31. J.J. McAleese, S.P. Stenning, S. Ashley Hypofractionated radiotherapy for poor prognosis malignant glioma matched pair survival analysis with MRC controls Radiother Oncol 67 2003 177 182
32. L. Kleinberg, T. Slick, C. Enger Short course radiotherapy is an appropriate option for most malignant glioma patients Int J Radiat Oncol Biol Phys 38 1997 31 36
33. M. Deutsch, S.B. Green, T.A. Strike Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma Int J Radiat Oncol Biol Phys 16 1989 1389 1396
34. J.C. Horiot, W. van den Bogaert, K.K. Ang European Organization for Research on Treatment of cancer trials using radiation therapy with multiple fractions per day. A 1978-1987 survey Front Radiat Ther Oncol 22 1988 149 161
35. M. Brada, G. Sharpe, B. Rajan Modifying radical radiotherapy in high grade gliomas Shortening the treatment time through acceleration Int J Radiat Oncol Biol Phys 43 1999 287 292
36. T.H. Wasserman, J. Stetz, T.L. Phillips Radiation Therapy Oncology Group clinical trials with misonidazole Cancer 47 1981 2382 2390
37. N.M. Bleehen, C.R. Wiltshire, P.N. Plowman A randomized study of misonidazole and radiotherapy for grade III and IV cerebral astrocytoma Br J Cancer 43 1981 436 442
38. EORTC Brain Tumor Group Misonidazole in radiotherapy of supratentorial malignant gliomas in adult patients A randomized double-blind study Eur J Cancer Clin Oncol 19 1983 39 42
39. R.C. Urtasun, D. Cosmatos, I. Delrowe Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma A comparison of short vs long intravenous dose schedule (RTOG86-12) Int J Radiol Biol Phys 27 1993 207 214
40. EORTC Brain Tumor Group Cisplatin does not enhance the effect of radiation therapy in malignant gliomas Eur J Cancer 27 1991 568 571
41. T. Wehbe, M. Glantz, H. Choy Histologic evidence of radiosensitizing effect of taxol in patients with astrocytomas J Neurooncol 39 1998 245 251
42. P. Carde, R. Timmerman, M.P. Mehta Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases J Clin Oncol 19 2001 2074 2083
43. F. Hochberg, M. Prados, C. Russell Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study J Neurooncol 32 1997 45 55
44. L. Kleinberg, S.A. Grossman, S. Piantadosi Phase I trial to determine the safety, pharmacodynamics and pharmacology of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme J Clin Oncol 17 1999 2593 2603
45. L. Kleinberg, S.A. Grossman, K. Carson Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy Results of a phase II NABTT CNS Consortium safety and efficacy study J Clin Oncol 20 2002 3149 3155
46. L.B. Harrison, M. Chadha, R.J. Hill Impact of tumor hypoxia and anemia on radiation therapy outcomes Oncologist 7 2002 492 508
47. P.K. Sneed, P.H. Gutin Interstitial radiation and hypertherermia M.S. Berger C.B. Wilson The Gliomas 1999 Saunders Philadelphia, PA 499 510
48. N.J. Laperriere, P.M. Leung, S. McKenzie Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma Int J Radiat Oncol Biol Phys 41 1998 1005 1011
49. S.B. Tatter, E.G. Shaw, M.L. Rosenblum An inflatable balloon catheter and liquid I-125 radiation source (Gliasite radiation therapy system) for treatment of recurrent malignant glioma Multi-center safety and feasibility trial J Neurosurg 99 2003 297 303
50. J.N. Sarkaria, M.P. Mehta, J.S. Loeffler Radiation Therapy Oncology Group Radiosurgery in the initial management of malignant gliomas survival comparison with the RTOG recursive partitioning analysis Int J Radiat Oncol Biol Phy 32 1995 931 941
51. R. Donehower, M. Abeloff, M.C. Perry Chemotherapy M. Abeloff J.O. Armitage A.S. Lichter Clinical Oncology 1995 Churchill Livingston New York, NY 201 218
52. Early Breast Cancer Trialist Collaborative Group Tamoxifen for early breast cancer. An overview of the randomised trials Lancet 351 1998 1451 1467
53. E.G. Mansour, R. Gray, A.H. Shatila Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer Ten-year analysis--An intergroup study J Clin Oncol 16 1998 3486 3492
54. C.G. Moertel, T.R. Fleming, J.S. Macdonald Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma A final report Ann Intern Med 122 1995 321 326
55. V.A. Levin, P. Silver, J. Hannigan Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas NCOG 6G61 final report Int J Radiat Oncol Biol Phys 18 1990 321 324
56. M.D. Prados, C. Scott, W.J. Curran Jr Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma A retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy J Clin Oncol 17 1999 3389 3395
57. The Medical Research Council Brain Tumour Working Party Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma A Medical Research Council Trial J Clin Oncol 19 2001 509 518
58. W.K.A. Yung, M.D. Prados, R. Yaya-Tur Temodal Brain Tumor Group Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse J Clin Oncol 17 1999 2762 2771
59. W.K.A. Yung, R.E. Albright, J. Olson A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83 2000 588 593
60. M. Brada, K. Hoang-Xuan, R. Rampling Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 2001 259 266
61. O.L. Chinot, S. Honore, H. Dufour Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy J Clin Oncol 19 2001 2449 2455
62. 6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma J Clin Oncol 16 1998 3851 3857
63. M.R. Gilbert, H.S. Friedman, J.F. Kuttesch A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy Neurooncology 4 2002 261 267
64. R. Stupp, P.-Y. Dietrich, S.O. Kraljevic Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 2002 1375 1382
65. S.A. Grossman, M. Wharam, V. Sheidler Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma J Clin Oncol 15 1997 2596 2603
66. S.A. Grossman, A. O'Neill, M. Grunnet Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme Eastern Cooperative Oncology Group trial 2394 J Clin Oncol 21 2003 1485 1491
67. S.P. Stenning, L.S. Freedman, N.M. Bleehen An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma Br J Cancer 56 1987 89 90
68. H.A. Fine, K.B.G. Dear, J.S. Loeffler Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 1993 2585 2597
69. L.A. Stewart Chemotherapy in adult high-grade glioma A systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 2002 1011 1018
70. L.M. DeAngelis, P.C. Burger, S.B. Green Malignant glioma who benefits from adjuvant chemotherapy? Ann Neurol 44 1998 691 695
71. H. Brem, S. Piantadosi, P.C. Burger The Polymer-Brain Tumor Treatment Group Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas Lancet 345 1995 1008 1012
72. M. Westphal, D.C. Hilt, E. Bortey A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neurooncology 5 2003 79 88
73. L. Kleinberg, J. Weingart, P. Burger Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma Implications for patient management Cancer Invest 22 2004 1 9
74. G. Voynov, S. Kaufman, T. Hong Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy Am J Clin Oncol 25 2002 606 611
75. C.O. Scharfen, P.K. Sneed, W.M. Wara High activity iodine-125 interstitial implant for gliomas Int J Radiat Oncol Biol Phys 24 1992 583 591
76. P.K. Sneed, D.A. Larson, P.H. Gutin Brachytherapy and hyperthermia for malignant astrocytomas Semin Oncol 21 1994 186 197
77. G.S. Bauman, P.K. Sneed, W.M. Wara Reirradiation of primary CNS Tumors Int J Radiat Oncol Biol Phys 36 1996 433 441
78. M. Arcicasa, M. Roncadin, E. Bidoli Reirradiation and lomustine in patients with relapsed high-grade gliomas Int J Radiat Oncol Biol Phys 43 1999 789 793
79. T. Veninga, H.A. Langendijk, B.J. Slotman Reirradiation of primary brain tumours survival, clinical response and prognostic factors Radiother Oncol 59 2001 127 137
80. H.K. Kim, A.F. Thornton, H.S. Greenberg Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy Am J Clin Oncol 20 1997 358 363
81. F. Boyle, S. Eller, S.A. Grossman The emperor's new clothes Vincristine distribution in experimental glioma Neurooncology 1 1999 300 (abstr)
82. M.R. Gilbert, J.G. Supko, T. Batchelor Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma Clin Cancer Res 9 2003 2940 2949
83. T.F. Cloughesy, E. Filka, J. Kuhn Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen Cancer 97 2003 2381 2386
84. H.S. Friedman, W.P. Petros, A.H. Friedman Irinotecan therapy in adults with recurrent or progressive malignant glioma J Clin Oncol 17 1999 1516 1525
85. S.A. Grossman, H. Brem, S. Piantadosi The NABTT CNS Consortium Organization, objectives and progress Cancer Control 5 1998 107 114
86. I.W. Tremont-Luckats, M.R. Gilbert Advances in molecular therapies in patients with brain tumors Cancer Control 10 2003 125 137
87. R.H. Bobo, D.W. Laske, A. Akbasak Convection-enhanced delivery of macromolecules in the brain Proc Natl Acad Sci USA 91 1994 2076 2080
88. E.P. Sipos, B. Tyler, S. Piantadosi Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors Cancer Chemother Pharmacol 39 1997 383 389
89. A. Olivi, S.A. Grossman, S. Tatter Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma a New approaches to Brain Tumor Therapy CNS Consortium Trial J Clin Oncol 21 2003 1845 1849
90. S.A. Grossman, S. Phuphanich, G. Lesser Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high grade gliomas J Clin Oncol 19 2001 3260 3266
91. S.A. Grossman, M. Zeltzman Practical considerations in the management of patients with primary brain tumors Neurologist 2 1996 130 138
92. D.C. Walsh, A.K. Kakkar Thromboembolism in brain tumors Curr Opin Pulm Med 7 2001 326 331
93. L.C. Marras, W.H. Geerts, J.R. Perry The risk of venous thromboembolism is increased throught the course of malignant glioma An evidence-based review Cancer 89 2000 640 646
94. D.E. Weissman Glucocorticoid treatment ofr brain metastases and epidural cord compressions. A review J Clin Oncol 6 1988 543 551
95. A.Z. Latif, D. Signorini, A. Gregor The costs of managing patients with malignant glioma at a neuro-oncology clinic Br J Neurosurg 12 1998 118 122
96. M.D. Silverstein, T.L. Cascino, W.S. Harmsen High-grade astrocytomas Resource use, clinical outcomes, and cost of care Mayo Clin Proc 71 1996 936 944
97. S.B. Green, D.P. Byar, M.D. Walker Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma Cancer Treat Rep 67 1983 121 132
98. W.R. Shapiro, S.B. Green, P.C. Burger A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma J Neurosurg 76 1992 772 781
99. S.C. Schold Jr, J.E. Herndon, P.C. Burger Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma J Clin Oncol 11 1993 77 83
100. R.P. Dinapoli, L.D. Brown, R.M. Arusell Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma J Clin Oncol 11 1993 1316 1321